Earnings Call · Q2 FY2025·2025-08-09

Q2 25EPS -14.29%·Rev n/aQ1 25EPS -14.29%·Rev n/aQ4 24EPS +10.04%·Rev n/aQ3 24EPS +7.89%·Rev n/a⚠ consensus missing

BIODESIX INC BDSX

Christopher F. Brinzey — Investor Relations or IR Representative

Scott Hutton — Chief Executive Officer

Robin Harper Cowie — Chief Financial Officer

−10.4%1d on move date−11.2% vs SPY3d−8.1%5d−11.2%

Research tier

Behavioral profile computed for 3 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more BDSX calls or request research access.

More BDSX calls Browse calls Request research access